Current NDC auxiliary source row compounder:105
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 70092-612
- Product Ndc
- 70092-612
- Product Ndc Digits
- 70092612
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- L.E.T. Gel 1.5 ml in 3 ml Top Syr
- Proprietary Name Suffix
- Nonproprietary Name
- L.E.T. Gel 1.5 ml in 3 ml Top Syr
- Dosage Form Name
- GEL
- Route Name
- TOPICAL
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- QuVa Pharma, Inc.
- Establishment Name
- QuVa Pharma, Inc.
- Establishment Fei
- Substance Name
- LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
- Active Ingredients Info
- 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL
- History Active Ingredients Raw
- LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
- History Active Ingredients Info Raw
- 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL
- History Dosage Raw
- GEL
- Dea Schedule
- Package Ndc Raw
- 70092-612-44
- Package Ndc
- 70092-612-44
- Package Ndc Digits
- 7009261244
- Package Ndc11
- 70092061244
- Package Description
- 1.5 mL in 1 SYRINGE (70092-612-44)
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:105
- Source Row Number
- 105
- Source Row Hash
- bd0023caffd6dc237f83bb25f0e9c9b97a48ef0fd03447f63796bfcc852264f2
- Import Run Id
- 20261122T170239Z
- Loaded At
- 2026-11-22 17:13:49
Exact raw FDA source fields#
{
"ROUTENAME": "TOPICAL",
"PRODUCTNDC": "70092-612",
"DEASCHEDULE": "",
"LABELERNAME": "QuVa Pharma, Inc.",
"SUBSTANCENAME": "LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE",
"DOSAGEFORMNAME": "GEL",
"NDCPACKAGECODE": "70092-612-44",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "L.E.T. Gel 1.5 ml in 3 ml Top Syr",
"REPORTINGPERIOD": "2026-1",
"NONPROPRIETARYNAME": "L.E.T. Gel 1.5 ml in 3 ml Top Syr",
"PACKAGEDESCRIPTION": "1.5 mL in 1 SYRINGE (70092-612-44) ",
"ACTIVEINGREDIENTSINFO": "60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:105
- Source Row Number
- 105
- Status Scope
- package
- Lookup Ndc
- 70092-612-44
- Lookup Ndc Digits
- 7009261244
- Product Ndc
- 70092-612
- Product Ndc Digits
- 70092612
- Package Ndc
- 70092-612-44
- Package Ndc Digits
- 7009261244
- Package Ndc11
- 70092061244
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- bd0023caffd6dc237f83bb25f0e9c9b97a48ef0fd03447f63796bfcc852264f2
- Import Run Id
- 20261122T170239Z
- Loaded At
- 2026-11-22 17:13:49